An association of silicone-gel breast implant rupture and fibromyalgia.

被引:8
作者
Brown S.L. [1 ]
Duggirala H.J. [1 ]
Pennello G. [1 ]
机构
[1] US Food and Drug Administration, Epidemiology Branch, Center for Devices and Radiological Health, HFZ-541, 1350 Piccard Drive, Rockville, 20850, MD
关键词
Fibromyalgia; Chronic Fatigue Syndrome; Breast Implant; Symptomatic Woman; Functional Somatic Syndrome;
D O I
10.1007/s11926-002-0037-6
中图分类号
学科分类号
摘要
Silicone-gel breast implant rupture is common. Silicone-gel from ruptured implants may escape the scar capsule that forms around breast implants and become "extracapsular silicone." Our previously published study found that women with extracapsular silicone gel were at higher risk of reporting that they were diagnosed with fibromyalgia. There has been a limited number of studies addressing this association in the literature. Some studies addressing the issue of silicone breast implants and connective tissue disease specifically exclude patients with fibromyalgia from the sample or do not include the syndrome in the analysis. Case series describing fibromyalgia in patients with implants have been published, but many of these papers lack information on extracapsular silicone and are not representative because the patients are typically from referral populations. In addition, most studies do not have control groups of women without implants for comparison or do not distinguish between saline and silicone implants. Additional observational studies of women from nonreferral populations are necessary to validate an association. These studies should provide information on how the rupture is diagnosed, state whether the rupture extended beyond the capsule, and provide an appropriate control group for comparison. The findings from such studies may be important to physicians as they describe potential risks associated with implants to their patients. These findings should also be important for regulatory decision making on silicone-gel breast implants.
引用
收藏
页码:293 / 298
页数:5
相关论文
共 111 条
[1]  
Silverman BG(1996)Reported complications of silicone gel breast implants: an epidemiologic review Ann Intern Med 124 744-756
[2]  
Brown SL(1992)The basis of the FDA’s decision on breast implants N Engl J Med 326 1713-1715
[3]  
Bright RA(1999)"Silicone related symptoms" are common in patients with fibromyalgia: no evidence for a new disease J Rheumatol 26 1172-1175
[4]  
Kessler DA(1994)Human adjuvant disease revisited: a review of eleven post-augmentation mammoplasty patients Clin Exp Rheumatol 12 477-481
[5]  
Wolfe F(1994)Risk of connectivetissue diseases and other disorders after breast implantation N Engl J Med 330 1697-1702
[6]  
Fenske TK(1996)Self-reported breast implants and connective-tissue diseases in female health professionals: a retrospective cohort study JAMA 275 616-621
[7]  
Davis P(1995)Silicone breast implants and the risk of connective-tissue disease and symptoms N Engl J Med 332 1666-1670
[8]  
Aaron SL(2001)Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women J Rheumatol 28 996-1003
[9]  
Gabriel SE(1990)The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee Arthritis Rheum 33 160-172
[10]  
O’Fallon WM(1995)The prevalence and characteristics of fibromyalgia in the general population Arthritis Rheum 38 19-28